Advances in stimuli-responsive hydrogels for liver disease therapy: mechanisms, applications, and translational perspectives.

Authors

Yilin Kuang, Yuhang Li, Chang Xu, Jinyan Chen, Huigang Li, Chenghao Cao, Peiru Zhang, Zhu Li, Rongsen Wang, Jinxin Xu, Hantian Yin, Jianyong Zhuo, Xiao Xu, Di Lu

Published in

Drug delivery and translational research. Aug 08, 2026. Epub Aug 08, 2026.

Abstract

The liver is a pivotal organ for metabolic and immune homeostasis, playing an essential role in maintaining physiological balance. Globally, the increasing incidence and mortality of liver diseases constitute a critical public health issue. However, conventional therapies are often limited by their inability to precisely target the pathological microenvironment of the liver, frequently resulting in either insufficient efficacy or excessive tissue damage. With notable biocompatibility, a tunable porous architecture, and smart responsive capabilities, hydrogels hold considerable promise as drug carriers for treating liver diseases. This review evaluates the core design principles and therapeutic value of stimuli-responsive hydrogels in liver disease, compares hydrogel systems, details their responsive modes, and highlights recent progress in antitumor, antioxidant, anti-fibrotic, and immunomodulatory therapy. Ultimately, the present review examines the key challenges and future directions for translating stimuli-responsive hydrogels into more precise, safe, and personalized therapies for liver diseases.

PMID:
42570970
Bibliographic data and abstract were imported from PubMed on 09 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.